Skip to search formSkip to main contentSkip to account menu

Aromatase Inhibitors

Known as: Androstenedione Aromatase Inhibitor, Estrogen Synthase Inhibitor, Estrogen Synthetase Inhibitor 
Any substance that inhibits aromatase, an enzyme responsible for the conversion of cholesterol to pregnenolone and the peripheral aromatization of… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2013
Review
2013
Though aromatase inhibitors (AIs) are an essential part of estrogen receptor-positive (ER+) breast cancer therapy, many patients… 
Review
2007
Review
2007
BACKGROUND Hormonal treatments for advanced or metastatic breast cancer, such as tamoxifen and the progestins megestrol acetate… 
Review
2007
Review
2007
The third‐generation aromatase inhibitors (AIs) anastrozole, exemestane and letrozole have largely replaced tamoxifen as the… 
Highly Cited
2006
Highly Cited
2006
BACKGROUND Aromatase inhibitors and inactivators have been extensively tested in patients with advanced breast cancer, but it is… 
Review
2006
Review
2006
Endometriosis is a common, chronic and estrogen-dependent gynaecological disorder associated with pelvic pain and infertility. In… 
Highly Cited
2005
Highly Cited
2005
Lung cancer is the most common cancer in the world. It is a highly lethal disease in women and men, and new treatments are… 
Review
2001
Review
2001
Estrogens are involved in numerous physiologic processes and have crucial roles in particular disease states, such as mammary… 
Highly Cited
1997
Highly Cited
1997
To determine whether local estrogen production takes place in endometriotic or adenomyotic tissues, in eutopic endometrium from…